Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1982 1
1983 3
1984 25
1985 50
1986 151
1987 209
1988 239
1989 244
1990 231
1991 259
1992 272
1993 248
1994 251
1995 287
1996 285
1997 292
1998 314
1999 377
2000 365
2001 431
2002 404
2003 478
2004 460
2005 521
2006 574
2007 511
2008 516
2009 535
2010 537
2011 586
2012 674
2013 715
2014 725
2015 784
2016 791
2017 823
2018 802
2019 848
2020 1015
2021 1020
2022 1078
2023 1049
2024 1154
2025 1343
2026 430

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,944 results

Results by year

Filters applied: . Clear all
Page 1
Levofloxacin.
Norrby SR. Norrby SR. Expert Opin Pharmacother. 1999 Nov;1(1):109-19. doi: 10.1517/14656566.1.1.109. Expert Opin Pharmacother. 1999. PMID: 11249554 Review.
Levofloxacin (DR-3355, Daiichi) is a new fluoroquinolone antibiotic which is the active isomer of ofloxacin (DL-8280, Daiichi). By removing the inactive isomer, the in vitro activity of levofloxacin is 8-128 times higher than that of ofloxacin. This me …
Levofloxacin (DR-3355, Daiichi) is a new fluoroquinolone antibiotic which is the active isomer of ofloxacin (DL-8280, Daiichi) …
Levofloxacin.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):119-21. doi: 10.1016/S1472-9792(08)70013-1. Tuberculosis (Edinb). 2008. PMID: 18486047 Review. No abstract available.
[Levofloxacin].
Azanza JR, Sádaba B, Quetglas EG, Escolar M. Azanza JR, et al. Rev Med Univ Navarra. 1998 Oct-Dec;42(4):220-5. Rev Med Univ Navarra. 1998. PMID: 10420933 Review. Spanish. No abstract available.
Levofloxacin revisited.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2011 Jul 11;53(1368):55. Med Lett Drugs Ther. 2011. PMID: 21738109 Review. No abstract available.
Levofloxacin-induced delirium.
Hakko E, Mete B, Ozaras R, Tabak F, Ozturk R, Mert A. Hakko E, et al. Clin Neurol Neurosurg. 2005 Feb;107(2):158-9. doi: 10.1016/j.clineuro.2004.05.006. Clin Neurol Neurosurg. 2005. PMID: 15708235 No abstract available.
[Levofloxacin nowadays].
Sidirenko SV. Sidirenko SV. Antibiot Khimioter. 2006;51(1):28-37. Antibiot Khimioter. 2006. PMID: 16734363 Review. Russian. No abstract available.
New fluoroquinolone antibiotics.
[No authors listed] [No authors listed] Drug Ther Bull. 1999 Jan;37(1):6-8. doi: 10.1136/dtb.1999.3716. Drug Ther Bull. 1999. PMID: 10562769 Review.
In 1993, we reviewed three fluoroquinolone antibiotics (ciprofloxacin, norfloxacin and ofloxacin). Since then, four more fluoroquinolones have been awarded marketing authorisations. Here we review the clinical evidence and discuss the place of two of these drugs, grepaflox …
In 1993, we reviewed three fluoroquinolone antibiotics (ciprofloxacin, norfloxacin and ofloxacin). Since then, four more fluoroquinol …
Levofloxacin, a second-generation fluoroquinolone.
North DS, Fish DN, Redington JJ. North DS, et al. Pharmacotherapy. 1998 Sep-Oct;18(5):915-35. Pharmacotherapy. 1998. PMID: 9758306 Review.
Levofloxacin, levo-isomer of the D,L-racemate ofloxacin, is a new fluoroquinolone antibiotic approved for use in the United States in December 1996. ...Drug interactions are uncommon with levofloxacin; however, coadministration with antacids or with other age …
Levofloxacin, levo-isomer of the D,L-racemate ofloxacin, is a new fluoroquinolone antibiotic approved for use in the United St …
The clinical pharmacokinetics of levofloxacin.
Fish DN, Chow AT. Fish DN, et al. Clin Pharmacokinet. 1997 Feb;32(2):101-19. doi: 10.2165/00003088-199732020-00002. Clin Pharmacokinet. 1997. PMID: 9068926 Review.
Levofloxacin is a fluoroquinolone antibiotic and is the optical S-(-) isomer of the racemic drug substance ofloxacin. ...Levofloxacin hemihydrate, the commercially formulated product, is 97.6% levofloxacin by weight. ...
Levofloxacin is a fluoroquinolone antibiotic and is the optical S-(-) isomer of the racemic drug substance ofloxacin. ...Le …
Levofloxacin-resistant pneumococcus.
Klugman KP. Klugman KP. Clin Infect Dis. 2000 Aug;31(2):626-7. doi: 10.1086/313958. Clin Infect Dis. 2000. PMID: 10987743 No abstract available.
20,944 results
You have reached the last available page of results. Please see the User Guide for more information.